BCL-6 is a kruppel-type zinc finger transcription factor spanning 706 amino acids. BCL-6 plays a central role in germinal centre (GC) formation, functioning as a regular of B lymphocyte growth and development by protecting GC B cells from undergoing DNA damage-induced apoptosis. Logarajah S et al. found that BCL-6 is involved in mammary epithelial differentiation, which may play a potential role in carcinogenesis. BCL-6 expression is mainly localized in GC B-cells. Surrounding mantle and marginal zone B cells, as well as plasma cells and Bone marrow B-cell precursors are negative for BCL-6. BCL-6 protein is commonly detected in GC neoplasms including follicular lymphomas, diffuse large B-cell lymphoma (DLBCL) and Burkitt's lymphomas. BCL-6 is not restricted to B-cell lineage, a considerable number of anaplastic large cell lymphoma also had BCL-6 expression, especially in ALK-positive cases.
BCL-6 is a kruppel-type zinc finger transcription factor spanning 706 amino acids. BCL-6 plays a central role in germinal centre (GC) formation, functioning as a regular of B lymphocyte growth and development by protecting GC B cells from undergoing DNA damage-induced apoptosis. Logarajah S et al. found that BCL-6 is involved in mammary epithelial differentiation, which may play a potential role in carcinogenesis. BCL-6 expression is mainly localized in GC B-cells. Surrounding mantle and marginal zone B cells, as well as plasma cells and Bone marrow B-cell precursors are negative for BCL-6. BCL-6 protein is commonly detected in GC neoplasms including follicular lymphomas, diffuse large B-cell lymphoma (DLBCL) and Burkitt's lymphomas. BCL-6 is not restricted to B-cell lineage, a considerable number of anaplastic large cell lymphoma also had BCL-6 expression, especially in ALK-positive cases.